Rchr
J-GLOBAL ID:201301059615076240   Update date: Jul. 31, 2024

Onodera Yasuhito

オノデラ ヤスヒト | Onodera Yasuhito
Affiliation and department:
Homepage URL  (1): http://kaken.nii.ac.jp/d/r/90435561.ja.html
Research field  (1): Molecular biology
Research keywords  (7): Synthetic Metabology ,  Synthetic Biology ,  乳癌 ,  糖代謝 ,  Warburg効果 ,  3次元培養 ,  シグナル伝達
Research theme for competitive and other funds  (13):
  • 2022 - 2026 放射線治療効果向上を目指した新規細胞標的~インフルエンサー・セルの探索~
  • 2021 - 2026 Optimization of cancer treatment based on intra-tumor metabolic geometry
  • 2019 - 2024 Research and development about helium and proton hybrid system with proton CT and Immuno-radiotherapy
  • 2021 - 2023 The development of methods to control enzyme activity using protein-protein splicing and virus-like particles
  • 2019 - 2022 Analysis of cell-to-cell communication to identify novel targets of radiotherapy
Show all
Papers (59):
  • Haruka Handa, Yasuhito Onodera, Tsukasa Oikawa, Shingo Takada, Koji Ueda, Daiki Setoyama, Takashi Yokota, Miwako Yamasaki, Masahiko Watanabe, Yoshizuki Fumoto, et al. MitoNEET reduces the mitochondrial oxidative phosphorylation during epithelial-mesenchymal transition. 2024
  • Tsukasa Oikawa, Junya Hasegawa, Haruka Handa, Naomi Ohnishi, Yasuhito Onodera, Ari Hashimoto, Junko Sasaki, Takehiko Sasaki, Koji Ueda, Hisataka Sabe. p53 ensures the normal behavior and modification of G1/S-specific histone H3.1 in the nucleus. Life Science Alliance. 2024. 7. 9. e202402835
  • Yuichi Mazaki, Haruka Handa, Yoshizuki Fumoto, Takahiro Horinouchi, Yasuhito Onodera. LRRK2 is involved in the chemotaxis of neutrophils and differentiated HL-60 cells, and the inhibition of LRRK2 kinase activity increases fMLP-induced chemotactic activity. Cell communication and signaling : CCS. 2023. 21. 1. 300-300
  • Tsukasa Oikawa, Junya Hasegawa, Haruka Handa, Naomi Ohnishi, Yasuhito Onodera, Ari Hashimoto, Junko Sasaki, Takehiko Sasaki, Koji Ueda, Hisataka Sabe. p53 secures the normal behavior of H3.1 histone in the nucleus by regulating nuclear phosphatidic acid and EZH2 during the G1/S phase. 2023
  • Tsukasa Oikawa, Junya Hasegawa, Naomi Ohnishi, Yasuhito Onodera, Ari Hashimoto, Junko Sasaki, Takehiko Sasaki, Koji Ueda, Hisataka Sabe. p53 controls the nuclear entry and epigenetic modification of H3.1 by downregulating nuclear phosphatidic acid. 2023
more...
MISC (72):
Professional career (2):
  • 修士(生命科学) (京都大学)
  • 博士(生命科学) (京都大学)
Work history (5):
  • 2020/12 - 現在 北海道大学大学院医学研究院 医理工学グローバルセンター 准教授
  • 2014/10 - 現在 北海道大学 医学(系)研究科(研究院) 講師
  • 2009/10 - 2014/09 北海道大学 医学(系)研究科(研究院) 助教
  • 2007/10 - 2009/09 ローレンスバークレー国立研究所 博士研究員
  • 2006/04 - 2007/09 大阪バイオサイエンス研究所 特別研究員
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page